Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

Author： Yonemori Kan   Katsumata Noriyuki   Kaneko Masayuki   Uno Hajime   Matsumoto Koji   Kouno Tsutomu   Shimizu Chikako   Ando Masashi   Takeuchi Masahiro   Fujiwara Yasuhiro  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.103, Iss.3, 2007-07, pp. : 313-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Chemotherapy in Early Breast Cancer: Optimal and Suboptimal Anthracycline-Containing Regimens

By Cocconi G.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 313-320

Springer Publishing Company

Access to resources Recommend Favorite

Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 257-264

Spandidos Publications

Access to resources Recommend Favorite

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

By Fernández-Sánchez Mónica   Gamboa-Dominguez Armando   Uribe Norma   García-Ulloa Ana   Flores-Estrada Diana   Candelaria Myrna   Arrieta Oscar  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 171-183

Humana Press, Inc

Access to resources Recommend Favorite

Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer

By Petit Thierry  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 387-391

Springer Publishing Company

Access to resources Recommend Favorite

Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane

By Okanami Yuko  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 182-188

Springer Publishing Company

Access to resources Recommend Favorite